Table 4.
Respiratory viruses detected in acute upper respiratory tract infections (URTIs) and acute lower respiratory tract infections (LTRIs)
| 14–25 years | 26–65 years | ≥66 years | Total number (%) | |||||
|---|---|---|---|---|---|---|---|---|
| URTIs | LRTIs | URTIs | LRTIs | URTIs | LRTIs | URTIs | LRTIs | |
| Patients tested | 1871 | 47 | 3275 | 159 | 386 | 70 | 5532 | 276 |
| Total positives | 710 (37.9)a | 12 (25.5) | 1088 (33.2) | 43 (27.0) | 129 (33.4) | 28 (40.0) | 1927 (34.8) | 83 (30.1) |
| Single detections | 666 (35.6) | 11 (23.4) | 1051 (32.1) | 40 (25.2) | 123 (31.9) | 25 (35.7) | 1840 (33.3) | 76 (27.5) |
| Dual detections | 43 (2.3) | 1 (2.1) | 37 (1.1) | 3 (1.9) | 6 (1.6) | 3 (4.3) | 86 (1.6) | 7 (2.5) |
| IFV A | 294 (15.7) | 3 (6.4) | 561 (17.1) | 15 (9.4) | 48 (12.4) | 11 (15.7) | 903 (16.3)a | 29 (10.5) |
| IFV B | 80 (4.3) | 1 (2.1) | 86 (2.6) | 1 (0.6) | 7 (1.8) | 2 (2.9) | 173 (3.1) | 4 (1.5) |
| IFV C | 10 (0.5) | 0 | 5 (0.2) | 0 | 0 | 0 | 15 (0.3) | 0 |
| HRVs | 148 (7.9) | 4 (8.5) | 188 (5.7) | 9 (5.7) | 24 (6.2) | 3 (4.3) | 360 (6.5) | 16 (5.8) |
| PIVs 1–4 | 87 (4.6) | 2 (4.3) | 125 (3.8) | 11 (6.9) | 20 (5.2) | 7 (10) | 232 (4.2) | 20 (7.3)b |
| EVs | 82 (4.4) | 2 (4.3) | 92 (2.8) | 3 (1.9) | 8 (2.1) | 1 (1.4) | 182 (3.3) | 6 (2.2) |
| HCoVs | 18 (1.0) | 0 | 24 (0.7) | 3 (1.9) | 17 (4.4) | 3 (4.3) | 59 (1.1) | 6 (2.2) |
| ADVs | 31 (1.7) | 0 | 16 (0.5) | 3 (1.9) | 1 (0.3) | 0 | 48 (0.9) | 3 (1.1) |
| RSV | 1 (0.1) | 1 (2.1) | 18 (0.5) | 1 (0.6) | 8 (2.1) | 1 (1.4) | 27 (0.5) | 3 (1.1) |
| HMPV | 4 (0.2) | 0 | 10 (0.3) | 0 | 2 (0.5) | 3 (4.3) | 16 (0.3) | 3 (1.1) |
ADV, adenovirus; EV, enterovirus; HCoV, human coronavirus; HMPV, human metapneumovirus; HRV, human rhinovirus; IFV, influenza virus; PIV, parainfluenza virus; RSV, respiratory syncytial virus.
aNumbers in parentheses are percentages.
bRepresents significant difference between the incidence of virus infection by chi‐square test.